Financhill
Buy
59

AKRO Quote, Financials, Valuation and Earnings

Last price:
$51.82
Seasonality move :
-12.73%
Day range:
$51.09 - $52.74
52-week range:
$17.86 - $58.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
4.90x
Volume:
816.6K
Avg. volume:
1.8M
1-year change:
115.43%
Market cap:
$3.6B
Revenue:
--
EPS (TTM):
-$3.78

Earnings Data

Next earnings date for AKRO
Feb 28
2025
Most recent earnings per share
-$1.05
Missed by $0.12
(Nov 8/2024)
Consensus Estimate
-$0.93
(Nov 8/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

AKRO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 -- -- -- -$1.11 --
02/28/2025 Q4 -- -- -- -$1.12 --
11/08/2024 Q3 -- -- -$1.05 -$0.93 -$0.12
08/09/2024 Q2 -- -- -$0.81 -$0.89 $0.08
05/10/2024 Q1 -- -- -$0.90 -$0.93 $0.03
02/29/2024 Q4 -- -- -$1.02 -$0.83 -$0.19
11/13/2023 Q3 -- -- -$0.71 -$0.69 -$0.02
08/11/2023 Q2 -- -- -$0.60 -$0.71 $0.11
05/15/2023 Q1 -- -- -$0.55 -$0.64 $0.09
03/17/2023 Q4 -- -- -$0.49 -$0.83 $0.34
11/04/2022 Q3 -- -- -$0.92 -$0.73 -$0.19
08/05/2022 Q2 -- -- -$0.77 -$0.86 $0.09
05/06/2022 Q1 -- -- -$0.74 -$0.84 $0.10
02/25/2022 Q4 -- -- -$0.93 -$0.81 -$0.12
11/12/2021 Q3 -- -- -$0.70 -$0.91 $0.21
08/13/2021 Q2 -- -- -$0.83 -$0.71 -$0.12
05/13/2021 Q1 -- -- -$0.43 -$0.94 $0.51
03/16/2021 Q4 -- -- -$0.86 -$0.60 -$0.26
11/12/2020 Q3 -- -- -$0.63 -$0.67 $0.04
08/12/2020 Q2 -- -- -$0.57 -$0.62 $0.05
05/13/2020 Q1 -- -- -$0.42 -$0.61 $0.19
03/16/2020 Q4 -- -- -$0.55 -$0.58 $0.03
11/12/2019 Q3 -- -- -$0.56 -$0.43 -$0.13
08/12/2019 Q2 -- -- -$0.26 -$0.36 $0.10

Akero Therapeutics Earnings Questions

  • How Much did Akero Therapeutics Generate in Revenue Last Quarter?

    Akero Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Akero Therapeutics Beat Earnings Last Quarter?

    Akero Therapeutics announced earnings per share of -$1.05 which represents a miss of analyst forecast a -$0.93 per share.

  • Is Akero Therapeutics Profitable?

    Akero Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Akero Therapeutics EPS Next Year?

    Akero Therapeutics's earnings are forecast to decrease from -$2.89 per share to -$3.95 per share next year representing a decrease of -37.38%.

  • When is Akero Therapeutics's Earnings Date?

    Akero Therapeutics's next earnings date is February 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Walmart Stock Fall?
Why Did Walmart Stock Fall?

Walmart (NYSE:WMT) tumbled in spite of strong Q4 results that…

Is Cadence Stock a Buy, Sell or Hold?
Is Cadence Stock a Buy, Sell or Hold?

Cadence Design Systems (NASDAQ:CDNS) has seen its stock move sharply…

Is PFE the Best Dividend Play in Its Industry?
Is PFE the Best Dividend Play in Its Industry?

By their inherent nature, established pharma companies face a demand…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Sell
48
Is MSFT Stock a Buy?

Market Cap: $3T
P/E Ratio: 35x

Alerts

Sell
2
GLOB alert for Feb 22

Globant SA [GLOB] is down 27.81% over the past day.

Sell
42
CELH alert for Feb 22

Celsius Holdings [CELH] is up 27.77% over the past day.

Buy
60
HIMS alert for Feb 22

Hims & Hers Health [HIMS] is down 25.64% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock